Biography
Translational pharmacologist and pharmacogenomics researcher with over 10 years of academic leadership and research experience. Expertise spans cancer pharmacology, molecular mechanisms of drug response, and genetic determinants of chemotherapy-induced toxicities. Currently focused on pharmacogenomics of chemotherapy-induced peripheral neuropathy (CIPN), integrating clinical genomics, biomarker discovery, and functional validation using electrophysiological and molecular pproaches. Proven ability to bridge mechanistic pharmacology with patient-level variability to advance precision oncology and personalized medicine.
